Global Multiple Sclerosis (MS) Drugs Market Analysis 2015-2019 and Forecast 2020-2025

1 Industry Overview

1.1 Multiple Sclerosis (MS) Drugs Industry

Figure Multiple Sclerosis (MS) Drugs Industry Chain Structure

1.1.1 Overview

1.1.2 Development of Multiple Sclerosis (MS) Drugs

1.2 Market Segment

1.2.1 Upstream

Table Upstream Segment of Multiple Sclerosis (MS) Drugs

1.2.2 Downstream

Table Application Segment of Multiple Sclerosis (MS) Drugs

Table Global Multiple Sclerosis (MS) Drugs Market 2015-2025, by Application, in USD Million

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Multiple Sclerosis (MS) Drugs Market by Type

3.1 By Type

3.1.1 Copaxone (Glatiramer Acetate, Copolymer 1)

Table Major Company List of Copaxone (Glatiramer Acetate, Copolymer 1)

3.1.2 Novantrone (Mitoxantrone)

Table Major Company List of Novantrone (Mitoxantrone)

3.1.3 Gilenya (Fingolimod, Fty720)

Table Major Company List of Gilenya (Fingolimod, Fty720)

3.1.4 Aubagio (Teriflunomide)

Table Major Company List of Aubagio (Teriflunomide)

3.1.5 Tecfidera (Dimethyl Fumarate)

Table Major Company List of Tecfidera (Dimethyl Fumarate)

3.1.6 Firategrast (Sb683699, T-0047)

Table Major Company List of Firategrast (Sb683699, T-0047)

3.1.7 Siponimod (Baf312)

Table Major Company List of Siponimod (Baf312)

3.1.8 Others

Table Major Company List of Others

3.2 Market Size

Table Global Multiple Sclerosis (MS) Drugs Market 2015-2019, by Type, in USD Million

Figure Global Multiple Sclerosis (MS) Drugs Market Growth 2015-2019, by Type, in USD Million

Table Global Multiple Sclerosis (MS) Drugs Market 2015-2019, by Type, in Volume

Figure Global Multiple Sclerosis (MS) Drugs Market Growth 2015-2019, by Type, in Volume

3.3 Market Forecast

Table Global Multiple Sclerosis (MS) Drugs Market Forecast 2020-2025, by Type, in USD Million

Table Global Multiple Sclerosis (MS) Drugs Market Forecast 2020-2025, by Type, in Volume

4 Major Companies List

4.1 Bayer AG (Company Profile, Sales Data etc.)

4.1.1 Bayer AG Profile

Table Bayer AG Overview List

4.1.2 Bayer AG Products & Services

4.1.3 Bayer AG Business Operation Conditions

Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.2 Bayhill Therapeutics (Company Profile, Sales Data etc.)

4.2.1 Bayhill Therapeutics Profile

Table Bayhill Therapeutics Overview List

4.2.2 Bayhill Therapeutics Products & Services

4.2.3 Bayhill Therapeutics Business Operation Conditions

Table Business Operation of Bayhill Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.3 Biogen Idec (Company Profile, Sales Data etc.)

4.3.1 Biogen Idec Profile

Table Biogen Idec Overview List

4.3.2 Biogen Idec Products & Services

4.3.3 Biogen Idec Business Operation Conditions

Table Business Operation of Biogen Idec (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.4 Cinnagen (Company Profile, Sales Data etc.)

4.4.1 Cinnagen Profile

Table Cinnagen Overview List

4.4.2 Cinnagen Products & Services

4.4.3 Cinnagen Business Operation Conditions

Table Business Operation of Cinnagen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.5 Daiichi Sankyo (Company Profile, Sales Data etc.)

4.5.1 Daiichi Sankyo Profile

Table Daiichi Sankyo Overview List

4.5.2 Daiichi Sankyo Products & Services

4.5.3 Daiichi Sankyo Business Operation Conditions

Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.6 Eli Lilly (Company Profile, Sales Data etc.)

4.6.1 Eli Lilly Profile

Table Eli Lilly Overview List

4.6.2 Eli Lilly Products & Services

4.6.3 Eli Lilly Business Operation Conditions

Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.7 Fast Forward Llc (Company Profile, Sales Data etc.)

4.7.1 Fast Forward Llc Profile

Table Fast Forward Llc Overview List

4.7.2 Fast Forward Llc Products & Services

4.7.3 Fast Forward Llc Business Operation Conditions

Table Business Operation of Fast Forward Llc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.8 Antisense Therapeutics (Company Profile, Sales Data etc.)

4.8.1 Antisense Therapeutics Profile

Table Antisense Therapeutics Overview List

4.8.2 Antisense Therapeutics Products & Services

4.8.3 Antisense Therapeutics Business Operation Conditions

Table Business Operation of Antisense Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.9 Apitope (Company Profile, Sales Data etc.)

4.9.1 Apitope Profile

Table Apitope Overview List

4.9.2 Apitope Products & Services

4.9.3 Apitope Business Operation Conditions

Table Business Operation of Apitope (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.10 Five Prime Therapeutics (Company Profile, Sales Data etc.)

4.10.1 Five Prime Therapeutics Profile

Table Five Prime Therapeutics Overview List

4.10.2 Five Prime Therapeutics Products & Services

4.10.3 Five Prime Therapeutics Business Operation Conditions

Table Business Operation of Five Prime Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.11 Genmab (Company Profile, Sales Data etc.)

4.11.1 Genmab Profile

Table Genmab Overview List

4.11.2 Genmab Products & Services

4.11.3 Genmab Business Operation Conditions

Table Business Operation of Genmab (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

4.12 Artielle Immunotherapeutics (Company Profile, Sales Data etc.)

4.12.1 Artielle Immunotherapeutics Profile

Table Artielle Immunotherapeutics Overview List

4.12.2 Artielle Immunotherapeutics Products & Services

4.12.3 Artielle Immunotherapeutics Business Operation Conditions

Table Business Operation of Artielle Immunotherapeutics (Sales Revenue, Cost, Gross Margin)

4.13 Genzyme (Company Profile, Sales Data etc.)

4.13.1 Genzyme Profile

Table Genzyme Overview List

4.13.2 Genzyme Products & Services

4.13.3 Genzyme Business Operation Conditions

Table Business Operation of Genzyme (Sales Revenue, Cost, Gross Margin)

4.14 Glaxosmithkline (Company Profile, Sales Data etc.)

4.14.1 Glaxosmithkline Profile

Table Glaxosmithkline Overview List

4.14.2 Glaxosmithkline Products & Services

4.14.3 Glaxosmithkline Business Operation Conditions

Table Business Operation of Glaxosmithkline (Sales Revenue, Cost, Gross Margin)

4.15 Gw Pharmaceuticals (Company Profile, Sales Data etc.)

4.15.1 Gw Pharmaceuticals Profile

Table Gw Pharmaceuticals Overview List

4.15.2 Gw Pharmaceuticals Products & Services

4.15.3 Gw Pharmaceuticals Business Operation Conditions

Table Business Operation of Gw Pharmaceuticals (Sales Revenue, Cost, Gross Margin)

4.16 Innate Immunotherapeutics (Company Profile, Sales Data etc.)

4.16.1 Innate Immunotherapeutics Profile

Table Innate Immunotherapeutics Overview List

4.16.2 Innate Immunotherapeutics Products & Services

4.16.3 Innate Immunotherapeutics Business Operation Conditions

Table Business Operation of Innate Immunotherapeutics (Sales Revenue, Cost, Gross Margin)

5 Market Competition

5.1 Company Competition

Table Global Multiple Sclerosis (MS) Drugs Sales Revenue 2015-2019, by Company, in USD Million

Table Global Multiple Sclerosis (MS) Drugs Sales Revenue Share 2015-2019, by Company, in USD Million

Figure Global Multiple Sclerosis (MS) Drugs Sales Revenue Share in 2019, by Company, in USD Million

Table Global Multiple Sclerosis (MS) Drugs Sales Volume 2015-2019, by Company, in Volume

Table Global Multiple Sclerosis (MS) Drugs Sales Volume Share 2015-2019, by Company, in Volume

Figure Global Multiple Sclerosis (MS) Drugs Sales Volume Share in 2019, by Company, in Volume

5.2 Regional Market by Company

Figure North America Multiple Sclerosis (MS) Drugs Market Concentration, in 2019

Figure Europe Multiple Sclerosis (MS) Drugs Market Market Concentration, in 2019

Figure Asia-Pacific Multiple Sclerosis (MS) Drugs MMarket Concentration, in 2019

Figure South America Multiple Sclerosis (MS) Drugs Market Concentration, in 2019

Figure Middle East & Africa Multiple Sclerosis (MS) Drugs Market Concentration, in 2019

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in RRMS

Figure Multiple Sclerosis (MS) Drugs Demand in RRMS, 2015-2019, in USD Million

Figure Multiple Sclerosis (MS) Drugs Demand in RRMS, 2015-2019, in Volume

6.1.2 Demand in SPMS

Figure Multiple Sclerosis (MS) Drugs Demand in SPMS, 2015-2019, in USD Million

Figure Multiple Sclerosis (MS) Drugs Demand in SPMS, 2015-2019, in Volume

6.1.3 Demand in PPMS

Figure Multiple Sclerosis (MS) Drugs Demand in PPMS, 2015-2019, in USD Million

Figure Multiple Sclerosis (MS) Drugs Demand in PPMS, 2015-2019, in Volume

6.1.4 Demand in PRMS

Figure Multiple Sclerosis (MS) Drugs Demand in PRMS, 2015-2019, in USD Million

Figure Multiple Sclerosis (MS) Drugs Demand in PRMS, 2015-2019, in Volume

6.2 Regional Demand Comparison

Table Regional Demand Comparison List

Table Major Application in Different Regions

6.3 Demand Forecast

Table Multiple Sclerosis (MS) Drugs Demand Forecast 2020-2025, by Application, in USD Million

Figure Multiple Sclerosis (MS) Drugs Market Growth 2020-2025, by Application, in USD Million

Figure Multiple Sclerosis (MS) Drugs Market Share in 2025, by Application, in USD Million

Table Multiple Sclerosis (MS) Drugs Demand Forecast 2020-2025, by Application, in Volume

Table Multiple Sclerosis (MS) Drugs Market Growth 2020-2025, by Application, in Volume

Table Multiple Sclerosis (MS) Drugs Market Share in 2025, by Application, in Volume

7 Region Operation

7.1 Regional Production

Table Multiple Sclerosis (MS) Drugs Production 2015-2019, by Region, in USD Million

Table Multiple Sclerosis (MS) Drugs Production 2015-2019, by Region, in Volume

7.2 Regional Market

Table Global Multiple Sclerosis (MS) Drugs Market 2015-2019, by Region, in USD Million

Table Global Multiple Sclerosis (MS) Drugs Market Share 2015-2019, by Region, in USD Million

Table Global Multiple Sclerosis (MS) Drugs Market 2015-2019, by Region, in Volume

Table Global Multiple Sclerosis (MS) Drugs Market Share 2015-2019, by Region, in Volume

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

Figure North America Multiple Sclerosis (MS) Drugs Market Size and Growth 2015-2019, in USD Million

Figure North America Multiple Sclerosis (MS) Drugs Market Size and Growth 2015-2019, in Volume

7.3.1.2 by Country (U.S., Canada, Mexico)

Table North America Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in USD Million

Table North America Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in Volume

7.3.2 Europe

7.3.2.1 Overview

Figure Europe Multiple Sclerosis (MS) Drugs Market Size and Growth 2015-2019, in USD Million

Figure Europe Multiple Sclerosis (MS) Drugs Market Size and Growth 2015-2019, in Volume

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

Table Europe Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in USD Million

Table Europe Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in Volume

7.3.3 Asia-Pacific

7.3.3.1 Overview

Figure Asia-Pacific Multiple Sclerosis (MS) Drugs Market Size and Growth 2015-2019, in USD Million

Figure Asia-Pacific Multiple Sclerosis (MS) Drugs Market Size and Growth 2015-2019, in Volume

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

Table Asia-Pacific Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in USD Million

Table Asia-Pacific Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in Volume

7.3.4 South America

7.3.4.1 Overview

Figure South America Multiple Sclerosis (MS) Drugs Market Size and Growth 2015-2019, in USD Million

Figure South America Multiple Sclerosis (MS) Drugs Market Size and Growth 2015-2019, in Volume

7.3.4.2 by Country (Brazil, Argentina etc.)

Table South America Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in USD Million

Table South America Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in Volume

7.3.5 Middle East & Africa

7.3.5.1 Overview

Figure Middle East & Africa Multiple Sclerosis (MS) Drugs Market Size and Growth 2015-2019, in USD Million

Figure Middle East & Africa Multiple Sclerosis (MS) Drugs Market Size and Growth 2015-2019, in Volume

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

Table Middle East & Africa Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in USD Million

Table Middle East & Africa Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in Volume

7.4 Regional Import & Export

7.5 Regional Forecast

Table Multiple Sclerosis (MS) Drugs Market Forecast 2020-2025, by Region, in USD Million

Table Multiple Sclerosis (MS) Drugs Market Forecast 2020-2025, by Region, in Volume

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

Table Price Factors List

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

Figure Marketing Channels Overview

9 Research Conclusion

Table Upstream Segment of Multiple Sclerosis (MS) Drugs

Table Application Segment of Multiple Sclerosis (MS) Drugs

Table Global Multiple Sclerosis (MS) Drugs Market 2015-2025, by Application, in USD Million

Table Major Company List of Novantrone (Mitoxantrone)

Table Major Company List of Gilenya (Fingolimod, Fty720)

Table Major Company List of Aubagio (Teriflunomide)

Table Major Company List of Tecfidera (Dimethyl Fumarate)

Table Major Company List of Firategrast (Sb683699, T-0047)

Table Major Company List of Siponimod (Baf312)

Table Major Company List of Others

Table Global Multiple Sclerosis (MS) Drugs Market 2015-2019, by Type, in USD Million

Table Global Multiple Sclerosis (MS) Drugs Market 2015-2019, by Type, in Volume

Table Global Multiple Sclerosis (MS) Drugs Market Forecast 2020-2025, by Type, in USD Million

Table Global Multiple Sclerosis (MS) Drugs Market Forecast 2020-2025, by Type, in Volume

Table Bayer AG Overview List

Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Bayhill Therapeutics Overview List

Table Business Operation of Bayhill Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Biogen Idec Overview List

Table Business Operation of Biogen Idec (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Cinnagen Overview List

Table Business Operation of Cinnagen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Daiichi Sankyo Overview List

Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eli Lilly Overview List

Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Fast Forward Llc Overview List

Table Business Operation of Fast Forward Llc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Antisense Therapeutics Overview List

Table Business Operation of Antisense Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Apitope Overview List

Table Business Operation of Apitope (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Five Prime Therapeutics Overview List

Table Business Operation of Five Prime Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Genmab Overview List

Table Business Operation of Genmab (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Artielle Immunotherapeutics Overview List

Table Business Operation of Artielle Immunotherapeutics (Sales Revenue, Cost, Gross Margin)

Table Genzyme Overview List

Table Business Operation of Genzyme (Sales Revenue, Cost, Gross Margin)

Table Glaxosmithkline Overview List

Table Business Operation of Glaxosmithkline (Sales Revenue, Cost, Gross Margin)

Table Gw Pharmaceuticals Overview List

Table Business Operation of Gw Pharmaceuticals (Sales Revenue, Cost, Gross Margin)

Table Innate Immunotherapeutics Overview List

Table Business Operation of Innate Immunotherapeutics (Sales Revenue, Cost, Gross Margin)

Table Global Multiple Sclerosis (MS) Drugs Sales Revenue 2015-2019, by Company, in USD Million

Table Global Multiple Sclerosis (MS) Drugs Sales Revenue Share 2015-2019, by Company, in USD Million

Table Global Multiple Sclerosis (MS) Drugs Sales Volume 2015-2019, by Company, in Volume

Table Global Multiple Sclerosis (MS) Drugs Sales Volume Share 2015-2019, by Company, in Volume

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Multiple Sclerosis (MS) Drugs Demand Forecast 2020-2025, by Application, in USD Million

Table Multiple Sclerosis (MS) Drugs Demand Forecast 2020-2025, by Application, in Volume

Table Multiple Sclerosis (MS) Drugs Market Growth 2020-2025, by Application, in Volume

Table Multiple Sclerosis (MS) Drugs Market Share in 2025, by Application, in Volume

Table Multiple Sclerosis (MS) Drugs Production 2015-2019, by Region, in USD Million

Table Multiple Sclerosis (MS) Drugs Production 2015-2019, by Region, in Volume

Table Global Multiple Sclerosis (MS) Drugs Market 2015-2019, by Region, in USD Million

Table Global Multiple Sclerosis (MS) Drugs Market Share 2015-2019, by Region, in USD Million

Table Global Multiple Sclerosis (MS) Drugs Market 2015-2019, by Region, in Volume

Table Global Multiple Sclerosis (MS) Drugs Market Share 2015-2019, by Region, in Volume

Table North America Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in USD Million

Table North America Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in Volume

Table Europe Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in USD Million

Table Europe Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in Volume

Table Asia-Pacific Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in USD Million

Table Asia-Pacific Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in Volume

Table South America Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in USD Million

Table South America Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in Volume

Table Middle East & Africa Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in USD Million

Table Middle East & Africa Multiple Sclerosis (MS) Drugs Market Size 2015-2019, by Country, in Volume

Table Multiple Sclerosis (MS) Drugs Market Forecast 2020-2025, by Region, in USD Million

Table Multiple Sclerosis (MS) Drugs Market Forecast 2020-2025, by Region, in Volume

Table Price Factors List